ArTara Therapeutics Inc (TARA)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

345 PARK AVENUE SOUTH NEW YORK, NY 10010

Proteon Therapeutics, Inc. researches and develops biopharmaceutical products. The Company produces pharmaceuticals to address the medical needs of patients with renal and vascular diseases.

Data as of 2021-05-08 11:37:36 -0400
Market Cap110.377 Million Shares Outstanding11.229 Million Avg 30-day Volume202.404 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.44 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.91404 52-week High/Low67.08 / 9.44 Next Earnings Date2021-07-30 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TARA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 50 49 2.04% 21 (1.26%) 20 (1.24%) 5.0%
13F shares: 8.776 Million 9.316 Million -5.79% 7.099 Million 7.658 Million -7.31%
% Ownership
New Positions: 6 16 -62.5% 3 10 -70.0%
Increased Positions 20 15 33.33% 5 7 -28.57%
Closed Positions 5 1 400.0% 2
Reduced Positions 12 11 9.09% 7 2 250.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

OLIVO MARTIN SEBASTIAN CHIEF MEDICAL OFFICER

  • Officer
4,451 2021-04-19 2

SMITH CYNTHIA

  • Director
0 2021-01-29 2

SHEFFERMAN JESSE CEO AND PRESIDENT

  • Officer
  • Director
0 2021-01-19 3

ZUMMO JACQUELINE CHF SCIENTIFIC OPERATIONS OFF

  • Officer
0 2021-01-19 2

DAVIS BLAINE CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-19 2

OPALEYE MANAGEMENT INC.

  • 10% Owner
2,558,472 2020-09-30 2

MARSHALL RANDALL

  • FORMER 10% OWNER
585,600 2020-09-14 16

FLANNELLY BARRY P

  • Director
0 2020-07-23 2

BESHAR LUKE M

  • Director
0 2020-06-09 1

BRAUNSTEIN SCOTT

  • Director
0 2020-06-09 1

SARGEN GREGORY

  • Director
0 2020-06-09 1

GARCEAU ROGER

  • Director
0 2020-06-09 1

SOLOMON MICHAEL EDWARD

  • Director
0 2020-06-09 1

LEVY RICHARD S

  • Director
0 2020-06-09 1

OPALEYE, L.P.

  • 10% Owner
2,208,472 2020-01-09 0

CASOY JULIO CHIEF MEDICAL OFFICER

  • Officer
45,500 2020-01-09 0

HAINES TIMOTHY

  • FORMER DIRECTOR AND 10% OWNER
2,144,517 2019-11-12 0

ABINGWORTH LLP

  • FORMER 10% OWNER
2,144,517 2019-11-12 0

FREUND JOHN GORDON

  • Director
2,175,882 2019-11-08 0

BURKE STEVEN KEITH SVP AND CHIEF MEDICAL OFFICER

  • Officer
147,248 2019-03-15 0

NOYES TIMOTHY P PRESIDENT AND CEO

  • Officer
  • Director
0 2019-01-31 0

ELDRIDGE, GEORGE ARTHUR SR VP, CFO, TREASR, ASST SECY

  • Officer
0 2019-01-18 0

GOTTLIEB DANIEL PHILIP VP CORPORATE DEVELOPMENT

  • Officer
0 2019-01-18 0

TONER E. SCOTT SENIOR VP OF COMMERCIAL

  • Officer
0 2019-01-18 0

KOWALSKY MATTHEW PAUL VP, LEGAL AND SECRETARY

  • Officer
0 2019-01-18 0

HARTMAN BRADLEY J VP, PEOPLE

  • Officer
0 2019-01-18 0

BOHLIN GAREN G

  • Director
0 2018-06-08 0

BIRNER HUBERT

  • Director
  • 10% Owner
0 2018-06-08 0

CANUTE SCOTT A

  • Director
0 2018-06-08 0

KINGSLEY STUART A

  • Director
0 2018-06-08 0

HASTINGS PAUL J

  • Director
0 2018-06-08 0

LEFF JONATHAN S

  • Director
0 2018-06-08 0

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2018-06-08 0

FLYNN JAMES E

DEERFIELD MANAGEMENT CO

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
1,224,899 2017-11-30 0

FLYNN JAMES E

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT CO

  • Director
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
1,224,899 2017-08-02 0

TVM LIFE SCIENCE VENTURES VI GMBH & CO KG

TVM LIFE SCIENCE VENTURES VI LP

BIRNER HUBERT

FISCHER STEFAN

SCHUHSLER HELMUT

  • Director
  • 10% Owner
0 2017-06-22 0

O'LEARY BRENDAN

  • Director
0 2016-06-09 0

PHELPS GREGORY D

  • Director
0 2015-06-02 0

KOBYZEV DMITRY

  • Director
  • 10% Owner
0 2015-06-02 0

SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P

SKYLINE VENTURE MANAGEMENT IV, LLC

FREUND JOHN GORDON

KANEKO YASUNORI

  • 10% Owner
1,432,930 2014-10-27 0

PHARMSTANDARD INTERNATIONAL S.A.

PUBLIC JOINT STOCK CO PHARMSTANDARD

  • 10% Owner
1,165,344 2014-10-27 0

TVM LIFE SCIENCE VENTURES VI GMBH & CO KG

FISCHER STEFAN

GOLL ALEXANDRA

SCHUHSLER HELMUT

TVM LIFE SCIENCE VENTURES VI LP

  • 10% Owner
3,846,186 2014-10-27 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2014-10-27 0

PRISM VENTURE PARTNERS V L P

PRISM VENTURE PARTNERS V-A LP

  • 10% Owner
No longer subject to file 2014-10-27 0

PRISM VENTURE PARTNERS V L P

  • Director
  • 10% Owner
0 2014-10-21 0

PRISM VENTURE PARTNERS V L P

O'LEARY BRENDAN

PRISM VENTURE PARTNERS V-A LP

  • Director
  • 10% Owner
0 2014-10-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

OLIVO MARTIN SEBASTIAN - Officer CHIEF MEDICAL OFFICER

2021-04-20 20:18:40 -0400 2021-04-19 A 120,000 a 120,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PROTARA THERAPEUTIC INC TARA 2021-05-10 22:15:04 UTC -0.7308 0.7808 80000
PROTARA THERAPEUTIC INC TARA 2021-05-10 21:45:02 UTC -0.7306 0.7806 80000
PROTARA THERAPEUTIC INC TARA 2021-05-10 21:15:02 UTC -0.7306 0.7806 80000
PROTARA THERAPEUTIC INC TARA 2021-05-10 20:45:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 20:15:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 19:45:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 19:15:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 18:45:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 18:15:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 17:45:02 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 17:15:03 UTC -0.7306 0.7806 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 16:45:03 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 16:15:03 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 15:45:03 UTC -0.7753 0.8253 90000
PROTARA THERAPEUTIC INC TARA 2021-05-10 15:15:03 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 14:45:04 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 14:15:04 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 13:45:04 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 13:15:03 UTC -0.7753 0.8253 100000
PROTARA THERAPEUTIC INC TARA 2021-05-10 12:45:02 UTC -0.7753 0.8253 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments